The Sales of autologous fat grafting are projected to expand at a healthy CAGR of close to 10% from 2021 to 2031. By application, breast augmentation holds the highest market share of over 45%.
The 21st century has been an era of advancements in cosmetics, where a range of new and advanced procedures are being made available to the public. Among these, preference for non-invasive or minimally-invasive procedures has enthused the population due to their minimal downtime and lower costs. One particular procedure gaining worldwide popularity is autologous fat grafting. As per Fact MR, the demand for autologous fat grafting will rise in response to the focus on cosmetic surgeries.
Over the years, disruptive products such as autologous fat grafting have met such customer demands, as autologous fat grafting is a minimally invasive method. In 2018, the number of people going for augmentation and reconstruction procedures in the U.S. was 6.2 Mn, out of which, the adoption % of autologous fat grafting procedures was 2.2%. Autologous fat grafting is also preferred for the correction of contour deformities in reconstructed breasts. The increasing prevalence of scar contractures is also expected to drive demand for autologous fat grafting.
The Sales of autologous fat grafting were valued at around US$ 172 Mn in 2020 and are projected to expand at a healthy CAGR of close to 10% through 2031.
Request a report sample to gain comprehensive market insights at
“Increasing prevalence of scar contractures and growing acceptance of aesthetic cosmetic procedures are expected to drive demand for integrated fat transfer systems over the coming years,” says a Fact.MR analyst.
Key Takeaways from Market Study
Integrated fat transfer systems accounted for over 50% of market share in 2020.
Breast augmentation is the most lucrative segment and holds a little less than half of the market share.
North America accounts for over half of the global autologous fat grafting market share, owing to technological advancements and increasing research & development activities in this region.
Hospitals account for over 48% value share, among end users.
The COVID19 pandemic has resulted in a temporary pause of all non-essential and elective procedures. Pharmaceutical manufacturers have been severely impacted, with companies reporting a significant drop in revenue due to supply chain issues.
The market in the U.S., U.K. and Germany to accelerate at around 10% CAGR each through 2031.
The market in China to surge ahead at a CAGR of around 12% over the next ten years.
Get Customization on this Research Report for specific research solutions
Strategies of Key Market Players
Key players in the autologous fat grafting industry are focused on introducing new, innovative products to boost their market share.
Alma Lasers (Sisram Medical), in 2019, launched BeautiFill for fat harvesting for autologous fat to restore volume to the face or body. It is the first laser-based procedure.
In 2017, MTF Biologics expanded its portfolio of plastic surgery products with LipoGrafter, which offers physicians a safer and effective method to harvest a patient’s fat and deposit it in areas where there is a need to add volume.
LifeCell Corporation introduced REVOLVE as an advanced adipose system used for the harvesting, aspiration, filtering, and transporting of high-quality autologous adipose tissue for aesthetic body contouring.
Key Segments of Market
Integrated Fat Transfer Systems
Aspiration and Harvesting Systems
Fat Processing Systems
Fat Injection Cannulas
Fat Harvesting Cannulas
LuerLok Infiltrator Cannulas
Cannula Connectors & Single Use Fat Transfer
Full Access of this Report is Available at
Autologous Fat Grafting for Breast Augmentation
Autologous Fat Grafting for Buttock Augmentation
Facial Fat Grafting
Autologous Fat Grafting for Hand Rejuvenation
Autologous Fat Grafting at Hospitals
Autologous Fat Grafting at On-site Clinics
Autologous Fat Grafting at Plastic Surgery Centers
The Middle East and Africa
Explore Fact.MR’s Coverage on the Healthcare Domain
Wound Healing Supplement Market: A recent study by Fact.MR on the Wound Healing Supplement Market offers a 5-year forecast analysis for the period 2021 – 2031. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.
Preparative Chromatography Market: Fact.MR’s extensive coverage of the Preparative Chromatography Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.
Retail Genomics Market: The Retail Genomics Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583